Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02452021 · ClinicalTrials.gov registry record
Pencil Beam Scanning Proton Radiotherapy for Esophageal Cancer
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 30
- Enrollment target
NCT02452021: Completed study, sponsored by Mayo Clinic.
NCT02452021 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 30 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02452021 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 30 participants
- Enrollment target
Study Summary
This is a prospective observational study designed to observe the toxicity and efficacy of PBS proton RT for patients with esophageal cancer undergoing trimodality therapy. The investigators hypothesize that PBS proton RT will be associated with a favorable adverse event profile and quality of life, with similar disease control outcomes, relative to historical comparisons of patients treated with photon RT.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2015-07 |
| Est. Completion | 2019-08-21 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02452021
The ClinicalTrials.gov registry entry for NCT02452021 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02452021 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02452021 about?
NCT02452021 is a clinical study titled "Pencil Beam Scanning Proton Radiotherapy for Esophageal Cancer". This is a prospective observational study designed to observe the toxicity and efficacy of PBS proton RT for patients with esophageal cancer undergoing trimodality therapy. The investigators hypothesize that PBS proton RT will be associated with a favorable adverse event profile and quality of life,...
What is the current status of trial NCT02452021?
This trial is currently completed. The enrollment target is 30 participants. The study started on 2015-07. Estimated completion is 2019-08-21.
Who is sponsoring clinical trial NCT02452021?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.